X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs ALEMBIC LTD - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH ALEMBIC LTD STERLING BIOTECH/
ALEMBIC LTD
 
P/E (TTM) x -0.4 58.4 - View Chart
P/BV x 0.0 2.4 0.6% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 STERLING BIOTECH   ALEMBIC LTD
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
ALEMBIC LTD
Mar-18
STERLING BIOTECH/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs1172 14.6%   
Low Rs334 10.0%   
Sales per share (Unadj.) Rs26.84.7 570.3%  
Earnings per share (Unadj.) Rs-15.06.1 -245.0%  
Cash flow per share (Unadj.) Rs-5.56.2 -87.5%  
Dividends per share (Unadj.) Rs00.20 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs54.940.7 135.0%  
Shares outstanding (eoy) m267.87267.03 100.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.311.3 2.3%   
Avg P/E ratio x-0.58.7 -5.4%  
P/CF ratio (eoy) x-1.38.5 -15.0%  
Price / Book Value ratio x0.11.3 9.7%  
Dividend payout %03.3 0.0%   
Avg Mkt Cap Rs m1,86214,139 13.2%   
No. of employees `0001.4NA-   
Total wages/salary Rs m547207 263.6%   
Avg. sales/employee Rs Th5,303.3NM-  
Avg. wages/employee Rs Th403.8NM-  
Avg. net profit/employee Rs Th-2,959.0NM-  
INCOME DATA
Net Sales Rs m7,1811,255 572.1%  
Other income Rs m43370 11.5%   
Total revenues Rs m7,2231,625 444.4%   
Gross profit Rs m947111 852.3%  
Depreciation Rs m2,54338 6,728.0%   
Interest Rs m4,3772 257,476.5%   
Profit before tax Rs m-5,931442 -1,342.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,92424 -8,034.7%   
Profit after tax Rs m-4,0071,630 -245.8%  
Gross profit margin %13.28.9 149.0%  
Effective tax rate %32.45.4 598.5%   
Net profit margin %-55.8129.8 -43.0%  
BALANCE SHEET DATA
Current assets Rs m14,3351,867 767.8%   
Current liabilities Rs m49,809591 8,425.1%   
Net working cap to sales %-494.0101.6 -486.0%  
Current ratio x0.33.2 9.1%  
Inventory Days Days40394 428.0%  
Debtors Days Days17174 232.0%  
Net fixed assets Rs m55,4321,791 3,095.2%   
Share capital Rs m268534 50.2%   
"Free" reserves Rs m13,93510,324 135.0%   
Net worth Rs m14,70110,858 135.4%   
Long term debt Rs m9,47841 23,004.5%   
Total assets Rs m73,98811,591 638.4%  
Interest coverage x-0.4260.9 -0.1%   
Debt to equity ratio x0.60 16,990.1%  
Sales to assets ratio x0.10.1 89.6%   
Return on assets %0.514.1 3.6%  
Return on equity %-27.315.0 -181.6%  
Return on capital %-6.415.2 -42.3%  
Exports to sales %25.91.5 1,675.8%   
Imports to sales %0.221.0 0.8%   
Exports (fob) Rs m1,86019 9,586.6%   
Imports (cif) Rs m12263 4.6%   
Fx inflow Rs m1,86019 9,586.6%   
Fx outflow Rs m25264 9.4%   
Net fx Rs m1,835-244 -750.7%   
CASH FLOW
From Operations Rs m1,719236 728.9%  
From Investments Rs m-3,148-224 1,405.4%  
From Financial Activity Rs m1,426-27 -5,360.9%  
Net Cashflow Rs m-3-15 23.0%  

Share Holding

Indian Promoters % 33.9 64.0 53.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.2 -  
FIIs % 9.9 9.7 102.1%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 26.1 150.6%  
Shareholders   21,482 54,701 39.3%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   PANACEA BIOTECH  DISHMAN PHARMA  TTK HEALTHCARE  NATCO PHARMA  BIOCON LTD  

Compare STERLING BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 170 Points Lower, Realty and FMCG Stocks Witness Selling(Closing)

After opening the day on a positive note, share markets in India witnessed volatile trading activity and ended in red.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY18); Net Profit Up 64.9% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, ALEMBIC LTD has posted a net profit of Rs 46 m (up 64.9% YoY). Sales on the other hand came in at Rs 332 m (up 0.9% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

Hurricanes Threaten Oil Spike, but the Saudis are Selling...(Vivek Kaul's Diary)

Sep 6, 2018

Oil prices are rising and could go even more higher amid rising tensions in Middle East.

Should You Be Worried About the Rising Dollar?(Chart Of The Day)

Sep 7, 2018

While the rupee has deprecated by about 5% annually since 1990 against the dollar, the BSE Sensex has returned 14% annually in the same period.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Sep 17, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS